Kidney Disease Center, The Fourth Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Jinhua, 322000, Zhejiang, China.
Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang, China.
Mol Cancer. 2020 Oct 14;19(1):149. doi: 10.1186/s12943-020-01266-7.
Renal cell carcinoma (RCC) is the most common malignant kidney tumor and has a high incidence rate. Circular RNAs (circRNAs) are noncoding RNAs with widespread distribution and diverse cellular functions. They are highly stable and have organ- and tissue-specific expression patterns. CircRNAs have essential functions as microRNA sponges, RNA-binding protein- and transcriptional regulators, and protein translation templates. Recent reports have shown that circRNAs are abnormally expressed in RCC and act as important regulators of RCC carcinogenesis and progression. Moreover, circRNAs have emerged as potential biomarkers for RCC diagnosis and prognosis and targets for developing new treatments. However, further studies are needed to better understand the functions of circRNAs in RCC. In this review, we summarize and discuss the recent research progress on RCC-associated circRNAs, with a focus on their potential for RCC diagnosis and targeted therapy.
肾细胞癌 (RCC) 是最常见的恶性肾肿瘤,发病率较高。环状 RNA (circRNA) 是一种具有广泛分布和多种细胞功能的非编码 RNA。它们高度稳定,具有器官和组织特异性的表达模式。circRNA 作为 microRNA 海绵、RNA 结合蛋白和转录调节剂以及蛋白质翻译模板发挥着重要作用。最近的报道表明,circRNA 在 RCC 中异常表达,并作为 RCC 发生和进展的重要调节因子。此外,circRNA 已成为 RCC 诊断和预后的潜在生物标志物和开发新治疗方法的靶点。然而,需要进一步的研究来更好地理解 circRNA 在 RCC 中的功能。在这篇综述中,我们总结和讨论了与 RCC 相关的 circRNA 的最新研究进展,重点关注它们在 RCC 诊断和靶向治疗中的潜力。